Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 1 Component(s) Includes a Live Web Event on 03/13/2024 at 2:00 PM (CDT)

    The ASTCT Pharmacy SIG Rx-cited: Clinical Conundrums Unplugged - March 2024 session will air on Wednesday, March 13, 2024 at 2 pm CDT/3 pm EDT.

    Have you ever found yourself completely stumped on how to approach a clinical case, wishing you could poll pharmacists from other institutions for an immediate answer? Have you ever been curious about other institutions’ transplant or immunotherapy standards, processes, or platforms, but didn’t know where to inquire? Have you posted a question on the SIG Discussion Board in hopes of generating conversation about a unique clinical situation? Have you ever wanted to network with colleagues more often than annually at the Tandem Meetings? 

    Then join us for a virtual round table discussion on any HCT and Immunotherapy topics, no-holds barred! Expect a rapid, informal Q&A session and discussion with your colleagues from around the country with the intent to generate immediate answers and make valuable connections! 

    Our inaugural ASTCT Pharmacy SIG’s Rx-Cited: Clinical Conundrums Unplugged will be held on Wednesday, March 13, at 2 pm CT/3 pm ET. This live session will focus on any and all topics related to hematopoietic cell transplantation and cellular therapy, related to clinical content, operational processes, general standards, and many more. ASTCT Pharmacy SIG Steering Committee will moderate and facilitate conversation from the audience via chat or open dialogue. This is open to all pharmacists practicing in transplantation and cellular therapy. If you have any questions you'd like us to answer at this session, you can submit them here: https://www.surveymonkey.com/r/D62G39L


  • Contains 1 Component(s)

    The ASTCT Pharmacy SIG November 2023 Journal Club will air on Wednesday, November 29, 2023 at 2 pm CST/3 pm EST.

    The ASTCT Pharmacy SIG November 2023 Journal Club will air on Wednesday, November 29, 2023 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q&A session. In the November Journal Club session, Drs. Patel and Gash will present on two articles related to (a) ciltacabtagene autoleucel or standard of care treatment in lenalidomide-refractory multiple myeloma and (b) post-transplant cyclophosphamide, abatacept, and a short course of tacrolimus (CAST) after peripheral blood haploidentical HSCT. 

    This session is intended for pharmacists and other members of the health care team who are involved in managing patients undergoing CAR T-cell therapy or hematopoietic stem cell transplant.

    Presenters & Articles

    Shikha P. Patel, PharmD, BCPS

    PGY-2 Pharmacy Resident

    Mayo Clinic

    Article: Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

     

    Kyle Gash, PharmD

    PGY-2 Pharmacy Resident

    Moffitt Cancer Center

    Article: PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

    Session Learning Objectives:

    Upon completion of the activity, participants should be able to:

    1. Review the role of CAR T-cell therapy in relapsed/refractory multiple myeloma
    2. Describe the mechanism of action of ciltacabtagene autoleucel
    3. Evaluate the efficacy and safety of ciltacabtagene autoleucel compared to standard regimens in the management of relapsed/refractory multiple myeloma
    4. Review graft-versus-host disease (GVHD) prophylaxis regimens following haploidentical hematopoietic stem cell transplantation (HCT)
    5. Analyze the safety and efficacy of post-transplant cyclophosphamide (PTCy), abatacept, and a short course of tacrolimus (CAST) for GVHD prevention
    6. Discuss the utility of the CAST regimen for GVHD prevention after haploidentical HCT



    ACCREDITED PROVIDER

    This activity is jointly provided by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT).

            image      image


    image

    In support of improving patient care, this activity has been planned and implemented by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

     

    CREDIT DESIGNATION

    Pharmacists

    image

    This knowledge-based activity, UAN JA0007204-9999-23-041-L01-P, qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

    All other healthcare professionals completing this course will be issued a statement of participation.

    The full CE information for this session can be found here.

  • Contains 10 Product(s)

    These are all the recordings and slides of the ten sessions from the live event the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy, hosted by ASTCT™, the CIBMTR® and the National Marrow Donor Program®(NMDP)/Be The Match®. Purchase this package to get access to all ten sessions at a discounted rate!

    These are the recordings and slides of the four sessions from the live event the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy, hosted by ASTCT™, the CIBMTR® and the National Marrow Donor Program®(NMDP)/Be The Match®. This live event took place on October 2 and 3, 2023. The two-day, hybrid workshop offered providers, payers, government agencies, and industry involved in the field of cell and gene therapy increased educational and advocacy opportunities. This workshop featured educational sessions bridging the gap among stakeholders, and identify ongoing needs and opportunities in the field for advocacy, measurement of value and impact, and sustainability.

    Purchase this package to get access to all ten sessions at a discounted rate! Individuals who registered to attend this event live are eligible to receive access to these recordings free of charge. Please email info@astct.org to receive your discount.

  • Contains 4 Component(s)

    This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

    This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

    Topics include:

    • CAR-T Barriers to Care
    • Point of Care Manufacture of CAR T cells
    • Point of Care Manufacturing: Enabling affordable and accessible advanced medicines

    Session Chair:

    • Boro Dropulić, PhD, MBA; Caring Cross

    Speakers: 

    • Armin Ghobadi, MD; Washington University School of Medicine
    • Marcos de Lima, MD; The Ohio State University Comprehensive Cancer Center
    • Boro Dropulić, PhD, MBA; Caring Cross



    • Contains 4 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      Topics include:

      • Pearls of Cellular Therapy Manufacturing Logistics
      • Clinical Use of Mesenchymal Stem Cells (MSCs) and MSC-Exosomes: Immune Suppression, Regenerative Medicine, and Gene Delivery
      • Virus-Specific T Cells

      Session Chair:

      • Elizabeth Shpall, MD; MD Anderson Cancer Center

      Speakers: 

      • Ray Hornung, MBA, MBCI, CEM, CBCP; NMDP
      • Elizabeth Shpall, MD; MD Anderson Cancer Center
      • Adrian Gee, PhD; Center for Cell & Gene Therapy, Baylor College of Medicine Houston



    • Contains 4 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      Topics include:

      • Equity of Access to HCT/ Cell Therapy
      • Need to Reduce Business Operations Complexity in Advancing Patients Through Cellular Therapy Treatment
      • Developing Tools to Widen Patient Access to Complex Therapies

      Session Chair:

      • Amy Emmert, MScPH, Dana-Farber Cancer Institute

      Speakers: 

      • Nandita Khera, MD, MPH; Mayo Clinic AZ 
      • Amy Emmert, MScPH, Dana-Farber Cancer Institute
      • Robert Richards, MS, MBA; Penn Medicine



    • Contains 4 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      Topics include:

      • Bispecifics vs CARs
      • Sequencing Bispecific Antibody Therapies and CAR-T cells in Multiple Myeloma
      • Future Directions for Solid Tumors

      Session Chair:

      • Neha Korde, MD; Memorial Sloan Kettering Cancer Center

      Speakers: 

      • Syed Abbas Ali, MD; John Hopkins University 
      • Neha Korde, MD; Memorial Sloan Kettering Cancer Center
      • Roisin O’Cearbhaill, MD; Memorial Sloan Kettering Cancer Center



    • Contains 5 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      Topics include:

      • Biological Drivers of CAR T Cell Failure
      • Patient-Specific Factors Impacting CAR T Cell Efficacy

      Session Chair:

      • Shannon Maude, MD, PhD; Children's Hospital of Pennsylvania/Perelman School of Medicine at the University of Pennsylvania

      Speakers: 

      • Nathan Singh, MD; Washington University School of Medicine
      • Regina Myers, MD; Children's Hospital of Pennsylvania/Perelman School of Medicine at the University of Pennsylvania



    • Contains 5 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Monday, October 2, 2023.

      Topics include:

      • Building a Cellular Therapy Program: Inpatient & Outpatient
      • Building your Program to be Able to Adapt to Solid Tumors
      • Is there an Optimal Cell Therapy Service Structure?

      Session Chair:

      • Sairah Ahmed, MD; MD Anderson Cancer Center

      Speakers: 

      • Krish Patel, MD; Swedish Cancer Institute 
      • Samer Srour, MB ChB, MS; MD Anderson Cancer Center
      • Gunjan Shah, MD, MS; Memorial Sloan Kettering Cancer Center


    • Contains 5 Component(s)

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Tuesday, October 3, 2023.

      This is the recording and slides of the session presented live at the 2023 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy. The event aired live on Tuesday, October 3, 2023.

      Topics include:

      • Allogeneic vs Autologous Therapies and How they Compete
      • Alternative Targets: Beyond B-Cell Malignancies
      • Allogeneic NK Cell Platform for Cancer Immunotherapy

      Session Chair:

      • Matthew Frigault, MD; MGH

      Speakers: 

      • Jay Spiegel, MD; University of Miami, Sylvester Comprehensive Cancer Center
      • Rayne Rouce, MD; Baylor College of Medicine/Texas Children's Hospital 
      • Veronika Bachanova, MD, PhD; University of Minnesota

      Panelist:

      • Elizabeth Shpall, MD; MD Anderson Cancer Center